New Zealand medicine safety and medical devices have announced the first approved electronic drug record in the country.
The registry was developed by the local company TONIQ, the first of its kind to be accepted for use in pharmacies in New Zealand.
Based on the release of the media, the digital record is integrated with the dispensing system to help maintain careful supervision of the number and type of medicines in storage.
“The record has proven well equipped to deal with user requirements and receive good notes from the participating pharmacists,” Joint Secretary General David Simore, who welcomed Midsavi’s permit.
In a separate statement, Tunaq said she was preparing to put her solution to “more than 850 pharmacists.”
Why do it matter
Simore said that New Zealand pharmacies maintains mainly controlled drug records, such as opioids and medical hemp, in physical paper records, which “can take great work to maintain.”
It is expected that this first approval will expect the digital registry of controlled drugs.[increase] Efficiency in pharmacies by allowing pharmacists to focus on patients instead of administrative tasks such as keeping manual records. “
The assistant minister said: “It is great that we see pharmacists who are able to reach a resource that can help manage their administrative duties. I know that these tasks can take a long time, and given our actual health system, I want to make sure to focus on only the most vital tasks.”
The biggest direction
The Digital Health Association hopes that the first approval of the electronic registry will be “a reflection of the interior to finance the digital technologies that started in Budget 2024. “” We may have turned into a corner, and digital health techniques have returned to the government’s agenda, “said the president of the association, Tony Way.
In 2022, the new government sought to cover the description of New Zealand electronic, allowing recipes Providing electronic texts for controlled drugs. Previously, the prescriptions had to provide a paper version signed of any prescription for a tight drug.
Meanwhile, TE What Oora has developed a FHIR applications interface that provides access to medicine information from Pharmaceutical Data Ware as part of the first phase of the Hira project that has been eliminated now.